156 related articles for article (PubMed ID: 17374707)
1. Determination of the elimination half-life of fibroblast growth factor-23.
Khosravi A; Cutler CM; Kelly MH; Chang R; Royal RE; Sherry RM; Wodajo FM; Fedarko NS; Collins MT
J Clin Endocrinol Metab; 2007 Jun; 92(6):2374-7. PubMed ID: 17374707
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia.
Imel EA; Peacock M; Pitukcheewanont P; Heller HJ; Ward LM; Shulman D; Kassem M; Rackoff P; Zimering M; Dalkin A; Drobny E; Colussi G; Shaker JL; Hoogendoorn EH; Hui SL; Econs MJ
J Clin Endocrinol Metab; 2006 Jun; 91(6):2055-61. PubMed ID: 16551733
[TBL] [Abstract][Full Text] [Related]
3. Persistent tumor-induced osteomalacia confirmed by elevated postoperative levels of serum fibroblast growth factor-23 and 5-year follow-up of bone density changes.
Zimering MB; Caldarella FA; White KE; Econs MJ
Endocr Pract; 2005; 11(2):108-14. PubMed ID: 15901526
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
Jonsson KB; Zahradnik R; Larsson T; White KE; Sugimoto T; Imanishi Y; Yamamoto T; Hampson G; Koshiyama H; Ljunggren O; Oba K; Yang IM; Miyauchi A; Econs MJ; Lavigne J; Jüppner H
N Engl J Med; 2003 Apr; 348(17):1656-63. PubMed ID: 12711740
[TBL] [Abstract][Full Text] [Related]
5. Locally aggressive and multifocal phosphaturic mesenchymal tumors: two unusual cases of tumor-induced osteomalacia.
Higley M; Beckett B; Schmahmann S; Dacey E; Foss E
Skeletal Radiol; 2015 Dec; 44(12):1825-31. PubMed ID: 26341245
[TBL] [Abstract][Full Text] [Related]
6. Tumor induced osteomalacia: associated with elevated circulating levels of fibroblast growth factor-7 in addition to fibroblast growth factor-23.
Bansal S; Khazim K; Suri R; Martin D; Werner S; Fanti P
Clin Nephrol; 2016 Jan; 85(1):57-62. PubMed ID: 26521888
[TBL] [Abstract][Full Text] [Related]
7. Hypophosphataemia due to FGF-23 producing B cell non-Hodgkin's lymphoma.
Elderman JH; Wabbijn M; de Jongh F
BMJ Case Rep; 2016 Apr; 2016():. PubMed ID: 27118742
[TBL] [Abstract][Full Text] [Related]
8. Clinical impact of somatostatin receptor scintigraphy in the management of tumor-induced osteomalacia.
Duet M; Kerkeni S; Sfar R; Bazille C; Lioté F; Orcel P
Clin Nucl Med; 2008 Nov; 33(11):752-6. PubMed ID: 18936605
[TBL] [Abstract][Full Text] [Related]
9. A paranasal tumor associated with tumor-induced osteomalacia.
Inokuchi G; Tanimoto H; Ishida H; Sugimoto T; Yamauchi M; Miyauchi A; Nibu K
Laryngoscope; 2006 Oct; 116(10):1930-3. PubMed ID: 17003734
[TBL] [Abstract][Full Text] [Related]
10. Tumor-induced osteomalacia: experience from a South American academic center.
González G; Baudrand R; Sepúlveda MF; Vucetich N; Guarda FJ; Villanueva P; Contreras O; Villa A; Salech F; Toro L; Michea L; Florenzano P
Osteoporos Int; 2017 Jul; 28(7):2187-2193. PubMed ID: 28341900
[TBL] [Abstract][Full Text] [Related]
11. Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia.
Takeuchi Y; Suzuki H; Ogura S; Imai R; Yamazaki Y; Yamashita T; Miyamoto Y; Okazaki H; Nakamura K; Nakahara K; Fukumoto S; Fujita T
J Clin Endocrinol Metab; 2004 Aug; 89(8):3979-82. PubMed ID: 15292336
[TBL] [Abstract][Full Text] [Related]
12. Osteomalacia by a mesenchymal-FGF23-producing tumour: Successful treatment with radiofrequency ablation. A case report.
Igney-Oertel A; Artunc F; Henes J; Hoffmann R; Clasen S
Joint Bone Spine; 2016 Oct; 83(5):603-4. PubMed ID: 27006265
[No Abstract] [Full Text] [Related]
13. Development of tumor-induced osteomalacia in a subcutaneous tumor, defined by venous blood sampling of fibroblast growth factor-23.
Ogura E; Kageyama K; Fukumoto S; Yagihashi N; Fukuda Y; Kikuchi T; Masuda M; Suda T
Intern Med; 2008; 47(7):637-41. PubMed ID: 18379151
[TBL] [Abstract][Full Text] [Related]
14. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia.
Yamazaki Y; Okazaki R; Shibata M; Hasegawa Y; Satoh K; Tajima T; Takeuchi Y; Fujita T; Nakahara K; Yamashita T; Fukumoto S
J Clin Endocrinol Metab; 2002 Nov; 87(11):4957-60. PubMed ID: 12414858
[TBL] [Abstract][Full Text] [Related]
15. Definitive surgical treatment of osteomalacia induced by skull base tumor and determination of the half-life of serum fibroblast growth factor 23.
Hana T; Tanaka S; Nakatomi H; Shojima M; Fukumoto S; Ikemura M; Saito N
Endocr J; 2017 Oct; 64(10):1033-1039. PubMed ID: 28768937
[TBL] [Abstract][Full Text] [Related]
16. Occult phosphaturic mesenchymal tumour of femur cortex causing oncogenic osteomalacia - diagnostic challenges and clinical outcomes.
Dutta D; Pandey RK; Gogoi R; Solanki N; Madan R; Mondal A; Dogra S; Thapa P
Endokrynol Pol; 2018; 69(2):205-210. PubMed ID: 29442350
[TBL] [Abstract][Full Text] [Related]
17. Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature.
Mori Y; Ogasawara T; Motoi T; Shimizu Y; Chikazu D; Tamura K; Fukumoto S; Takato T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e57-63. PubMed ID: 20219587
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of systemic venous sampling of FGF23 for identifying tumours responsible for tumour-induced osteomalacia.
Ito N; Shimizu Y; Suzuki H; Saito T; Okamoto T; Hori M; Akahane M; Fukumoto S; Fujita T
J Intern Med; 2010 Oct; 268(4):390-4. PubMed ID: 20698924
[No Abstract] [Full Text] [Related]
19. [Hypophosphatemic osteomalacia].
Bullmann C; Benker G; Rosien U; Delling G; Siggelkow H; Schulte HM
Med Klin (Munich); 2008 Sep; 103(9):671-5. PubMed ID: 18813890
[TBL] [Abstract][Full Text] [Related]
20. Surgical Treatments of Tumor-Induced Osteomalacia Lesions in Long Bones: Seventeen Cases with More Than One Year of Follow-up.
Wang H; Zhong D; Liu Y; Jiang Y; Qiu G; Weng X; Xing X; Li M; Meng X; Li F; Zhu Z; Yu W; Xia W; Jin J
J Bone Joint Surg Am; 2015 Jul; 97(13):1084-94. PubMed ID: 26135075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
